DK406386D0 - Heterocycliske forbindelser, deres fremstilling og farmaceutiske anvendelse - Google Patents

Heterocycliske forbindelser, deres fremstilling og farmaceutiske anvendelse

Info

Publication number
DK406386D0
DK406386D0 DK406386A DK406386A DK406386D0 DK 406386 D0 DK406386 D0 DK 406386D0 DK 406386 A DK406386 A DK 406386A DK 406386 A DK406386 A DK 406386A DK 406386 D0 DK406386 D0 DK 406386D0
Authority
DK
Denmark
Prior art keywords
alkyl
phenyl
hydrogen
group
atoms
Prior art date
Application number
DK406386A
Other languages
English (en)
Other versions
DK406386A (da
Inventor
Roger Charles Brown
David Hulme Robinson
John Dixon
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858521697A external-priority patent/GB8521697D0/en
Priority claimed from GB858524932A external-priority patent/GB8524932D0/en
Priority claimed from GB858530143A external-priority patent/GB8530143D0/en
Priority claimed from GB868609793A external-priority patent/GB8609793D0/en
Priority claimed from GB868612060A external-priority patent/GB8612060D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of DK406386D0 publication Critical patent/DK406386D0/da
Priority claimed from SU874202059A external-priority patent/RU1804458C/ru
Publication of DK406386A publication Critical patent/DK406386A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK406386A 1985-08-31 1986-08-26 Heterocycliske forbindelser, deres fremstilling og farmaceutiske anvendelse DK406386A (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB858521697A GB8521697D0 (en) 1985-08-31 1985-08-31 Nitrogen & sulphur heterocycles
GB858524932A GB8524932D0 (en) 1985-10-09 1985-10-09 Nitrogen & sulphur heterocycles
GB858530143A GB8530143D0 (en) 1985-12-06 1985-12-06 Nitrogen
GB868609793A GB8609793D0 (en) 1986-04-22 1986-04-22 Nitrogen containing heterocycles
GB868612060A GB8612060D0 (en) 1986-05-17 1986-05-17 Nitrogen containing heterocycles
SU874202059A RU1804458C (ru) 1985-08-31 1987-02-09 Способ получени производных 1,3,4-тиадиазол-2-карбоновых кислот или их фармацевтически приемлемых солей, сложных эфиров или амидов

Publications (2)

Publication Number Publication Date
DK406386D0 true DK406386D0 (da) 1986-08-26
DK406386A DK406386A (da) 1987-03-01

Family

ID=27546912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK406386A DK406386A (da) 1985-08-31 1986-08-26 Heterocycliske forbindelser, deres fremstilling og farmaceutiske anvendelse

Country Status (19)

Country Link
US (1) US4927822A (da)
EP (1) EP0217519B1 (da)
JP (1) JPH0788365B2 (da)
KR (1) KR940009528B1 (da)
AT (1) ATE72431T1 (da)
AU (1) AU591165B2 (da)
BE (1) BE905351A (da)
CA (1) CA1305286C (da)
CH (1) CH671397A5 (da)
DK (1) DK406386A (da)
FI (1) FI87205C (da)
FR (1) FR2586679B1 (da)
GR (1) GR862234B (da)
IE (1) IE59432B1 (da)
IL (1) IL79841A (da)
LU (1) LU86569A1 (da)
NO (1) NO166180C (da)
NZ (1) NZ217398A (da)
PT (1) PT83277B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87616B (pt) * 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas
GB8825541D0 (en) * 1988-11-01 1988-12-07 Fisons Plc Formulation
WO1994020460A1 (en) * 1993-03-11 1994-09-15 Smithkline Beecham Corporation Chemical compounds
DK1454903T3 (da) * 2001-12-11 2010-11-22 Kyowa Hakko Kirin Co Ltd Thiadiazolinderivater til behandling af cancer
ES2394850T3 (es) * 2003-04-18 2013-02-06 Kyowa Hakko Kirin Co., Ltd. Inhibidor de cinesina mitótica
CA2528433A1 (en) * 2003-06-10 2004-12-23 Kyowa Hakko Kogyo Co., Ltd. Thiadiazoline derivative
WO2004111023A1 (ja) * 2003-06-10 2004-12-23 Kyowa Hakko Kogyo Co., Ltd. チアジアゾリン-1-オキシド誘導体
CA2542034A1 (en) * 2003-10-10 2005-04-21 Kyowa Hakko Kogyo Co., Ltd. Thiadiazoline derivatives
US7449486B2 (en) 2004-10-19 2008-11-11 Array Biopharma Inc. Mitotic kinesin inhibitors and methods of use thereof
CA2602559A1 (en) * 2005-03-22 2006-09-28 Kyowa Hakko Kogyo Co., Ltd. Agent for treatment of hematopoietic tumor
TW200714593A (en) * 2005-03-22 2007-04-16 Kyowa Hakko Kogyo Kk Agent for treatment of solid tumor
UA95907C2 (en) 2005-05-02 2011-09-26 Эррей Биофарма Инк. Mitotic kinesin inhibitors and methods of use thereof
US7910611B2 (en) 2005-06-24 2011-03-22 Kyowa Hakko Kirin Co., Ltd. Therapeutic agent for restenosis
DE102006002065B4 (de) * 2006-01-16 2007-11-29 Infineon Technologies Austria Ag Kompensationsbauelement mit reduziertem und einstellbarem Einschaltwiderstand
MX2009001877A (es) 2006-08-21 2009-03-02 Synta Pharmaceuticals Corp Compuestos para el tratamiento de trastornos proliferativos.
WO2008042928A2 (en) * 2006-10-03 2008-04-10 Array Biopharma, Inc. Oxadiazole and thiadiazole derivatives as mitotic kinesin inhibitors and methods of use thereof
EP2225201A2 (en) * 2007-11-28 2010-09-08 Synta Pharmaceuticals Corp. Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide)
TW200940050A (en) * 2007-11-28 2009-10-01 Synta Pharmaceuticals Corp Polymorphs of N-malonyl-bis(N'-methyl-N'-thiobenzoylhydrazide)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091024A (en) 1976-12-03 1978-05-23 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
US4198517A (en) * 1976-12-03 1980-04-15 E. R. Squibb & Sons, Inc. Histidine derivatives
IL58849A (en) 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4254267A (en) * 1979-10-25 1981-03-03 E. R. Squibb & Sons, Inc. Mercaptoacyldihydropyrazole carboxylic acid derivatives
US4312990A (en) * 1980-09-11 1982-01-26 E. R. Squibb & Sons, Inc. 1-Mercaptoacyl-3-[(aminosulfonyl) phenyl]-4,5-dihydro-1H-pyrazole-5-carboxylic acid
GR75019B (da) * 1980-09-17 1984-07-12 Univ Miami

Also Published As

Publication number Publication date
ATE72431T1 (de) 1992-02-15
FI87205C (fi) 1992-12-10
DK406386A (da) 1987-03-01
NO863457L (no) 1987-03-02
FR2586679B1 (fr) 1988-12-30
AU6179886A (en) 1987-03-05
EP0217519B1 (en) 1992-02-05
FI87205B (fi) 1992-08-31
IL79841A (en) 1992-02-16
FI863488A0 (fi) 1986-08-28
US4927822A (en) 1990-05-22
NO863457D0 (no) 1986-08-28
NO166180B (no) 1991-03-04
CA1305286C (en) 1992-07-14
GR862234B (en) 1986-12-31
NZ217398A (en) 1989-04-26
NO166180C (no) 1991-06-19
CH671397A5 (da) 1989-08-31
BE905351A (fr) 1987-03-02
JPH0788365B2 (ja) 1995-09-27
FR2586679A1 (fr) 1987-03-06
EP0217519A1 (en) 1987-04-08
AU591165B2 (en) 1989-11-30
PT83277A (en) 1986-09-01
IE862322L (en) 1987-02-28
KR870002107A (ko) 1987-03-30
FI863488A (fi) 1987-03-01
KR940009528B1 (ko) 1994-10-14
LU86569A1 (fr) 1986-12-02
PT83277B (pt) 1989-03-30
JPS6253976A (ja) 1987-03-09
IE59432B1 (en) 1994-02-23
IL79841A0 (en) 1986-11-30

Similar Documents

Publication Publication Date Title
DK406386A (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske anvendelse
AR012489A1 (es) Tiofenopiridinas antagonistas del factor de liberacion de corticotropina. procedimiento para su preparacion, el uso de las mismas en la preparacionde un medicamento, composicion farmaceutica que las comprende, procedimiento para la preparacion de dicha composicion, un compuesto intermediario y
FI894061A0 (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
NO924949D0 (no) Piperidylsubstituerte indoler
ES520526A0 (es) Procedimiento para la obtencion de derivados de piridina.
NO840526L (no) Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter
NO982927L (no) Biologisk aktive benzotiazolon etanaminer
PT99502A (pt) Processo para a preparacao de novos derivados de imidazol
YU140491A (sh) 6-supstituisani-tetrahidrobenz(c,d) indoli
ES8401456A1 (es) Procedimiento para la preparacion de 2-aminometilfenoles.
ES8604104A1 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina
MY101878A (en) 1,3,4-thiadiazole
SE8302452D0 (sv) Method for treatment of senile dementia
DK104488A (da) Acetamider afledt af 2,3-dihydro-3-phenyl-2-benzofuranon, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem
DK513281A (da) Fremgangsaade til fremstilling af 3-thiovinylcephalosproner
ES8608509A1 (es) Procedimiento para preparar nuevos derivador de 2-(1-imidazolil)-etanol
DK0461012T3 (da) Derivater af ((1-arylpyrrolidin-2-yl)methyl)piperazin, fremstillingen heraf og deres terapeutiske anvendelse
ES8103749A1 (es) Procedimiento para la preparacion de 5,6,7,8-tetrahidropira-zolo (3,4-b)(1,5)diazepin-1h,4h-5,7-dionas

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment